Tag Archives: Novo

Novo Nordisk Stock Got Battered. Think Twice Before Buying the Dip.  Barron’s Novo Nordisk slides further on US competition, new CEO concerns  Reuters Novo Nordisk’s stock plunge isn’t surprising. Why companies clear the deck for new CEOs  CNBC Novo Nordisk Shares Plummet as Competition Weighs on Sales  The Wall Street Journal Novo Nordisk stock crashes after company cuts sales, profit outlook on weight-loss drug …

Topline Shares of Wegovy and Ozempic maker Novo Nordisk fell more than 21% Tuesday, pacing what would be the stock’s largest plunge since the 1980s after the Danish pharmaceutical firm cut its full-year guidance for sales and profit, as growth for its obesity and weight loss treatments are expected to slow in the U.S. The Danish firm said weaker Wegovy …

Novo Nordisk lowered its sales forecast for obesity drug Wegovy, citing competition from compounded versions. Scott Olson/Getty Images hide caption toggle caption Scott Olson/Getty Images Novo Nordisk’s shares plunged more than 20% Tuesday, after the company cut the forecast for its flagship obesity drug. Before the markets opened, the company announced that sales of its obesity medicine, Wegovy, are expected …

Novo Nordisk, Ozempic Drugmaker, Sees Stock Plunge 20% After Profit Warning  The New York Times Novo Nordisk Shares Plummet as Competition Weighs on Sales  The Wall Street Journal Novo Nordisk shares plunge 23% after Wegovy maker names new CEO, cuts full-year guidance  CNBC Drugmaker Novo Nordisk slashes Wegovy sales forecasts, blaming compounding  NPR Wegovy maker Novo’s profit warning triggers $70 billion share rout  Reuters Source …

Novo Nordisk Shares Plummet as Competition Weighs on Sales  The Wall Street Journal Novo Nordisk, Ozempic Drugmaker, Sees Stock Plunge 20% After Profit Warning  The New York Times Novo Nordisk outgoing CEO blames compounded GLP-1s for decline in 2025 outlook  Yahoo Finance Novo Nordisk shares plunge 23% after Wegovy maker names new CEO, cuts full-year guidance  CNBC Novo Stock (NVO) Tumbles. Ozempic, Wegovy Maker …

SoFi, UnitedHealth, Novo Nordisk, UPS, Boeing, Sarepta, Whirlpool, and More Movers  Barron’s Stocks making the biggest moves premarket: Novo Nordisk, Whirlpool, Sarepta Therapeutics and more  CNBC Procter & Gamble, Sarepta Therapeutics, Cadence Design Systems  TradingView Source link

Novo Stock (NVO) Tumbles. Ozempic, Wegovy Maker Has New CEO, Cuts U.S. Outlook  Barron’s Novo Nordisk shares plunge 17% after Wegovy-maker cuts full-year guidance  CNBC Novo Promotes Insider to CEO After Weight-Loss Drug Slowdown  Bloomberg Europe shares dented as Novo warning burns $92 bln in market cap  Reuters Ozempic And Wegovy Maker Cuts Outlook In Surprise Move, Picks New CEO  Yahoo Finance Source link

Obesity drugmaker Novo Nordisk plunges as it cuts forecasts again  Reuters Novo Nordisk shares plunge 17% after Wegovy-maker cuts full-year guidance  CNBC Novo Lowers Forecast as Weight-Loss Drug Sales Fall Short  Bloomberg.com Ozempic And Wegovy Maker Cuts Outlook In Surprise Move, Picks New CEO  Yahoo Finance Novo Nordisk issues profit warning as competition — legal and otherwise — hits Wegovy, Ozempic  MarketWatch Source link

Novo Nordisk issues profit warning as competition — legal and otherwise — hits Wegovy, Ozempic  MarketWatch Novo Nordisk shares plunge 17% after Wegovy-maker cuts full-year guidance  CNBC Obesity drugmaker Novo Nordisk cuts 2025 sales growth, operating profit outlook  Yahoo Finance Novo Lowers Forecast as Weight-Loss Drug Sales Fall Short  Bloomberg Novo Nordisk Stock Plummets After Ozempic, Wegovy Maker Cuts U.S. Outlook  Barron’s Source link

Medical bottles and a syringe are seen with the Novo Nordisk logo displayed on a screen in the background. Nurphoto | Nurphoto | Getty Images Danish pharmaceutical giant Novo Nordisk on Tuesday cut its full-year sales and profit guidance, citing weaker growth expectations for its blockbuster Wegovy obesity drug in the key U.S. market. The company also named Maziar Mike …